Abstract
Clinically significant occlusive vascular lesions contain more extracellular matrix (ECM) proteins and lipid deposition than healthy vascular tissue. The events leading to this condition remain unresolved. One possibility is that ECM deposition may exceed ECM degradation which would contribute to the expansion of the vascular lesion. Utilizing lean (+/?) and insulin-resistant, corpulent (cp/cp) JCR:LA-cp rats, which are predisposed to develop vascular lesions, we have compared the matrix metalloproteinase (MMP) profile prior to the development of significant vascular lesions. Analysis of serum MMPs revealed that cp/cp rats have lower circulating levels than (+/?) controls. This is observed prior to the development of any noticeable atherosclerotic lesions. It also occurs as the hyperinsulinemia and insulin resistance is first developing in these rats. Female corpulent animals, which are less prone to develop vascular lesions, also exhibit a depressed serum MMP profile of a similar magnitude to their male counterparts. Primary vascular smooth muscle cells isolated from cp/cp animals also showed a reduction in secreted MMP compared with cells derived from +/? lean controls. We conclude that reduced MMP levels could lead to increased ECM accumulation and thus contribute to early vascular lesion formation. (Mol Cell Biochem 249: 151–155, 2003)
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Schwartz SM, deBlois D, O’Brien ER: The intima. Soil for atherosclerosis and restenosis. Circ Res 77: 445–465, 1995
Galis ZS, Sukhova GK, Lark MW, Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94: 2493–2503, 1994
Pauly RR, Passaniti A, Bilato C, Monticone R, Cheng L, Papadopoulos N, Gluzband YA, Smith L, Weinstein C, Lakatta EG: Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res 75: 41–54, 1994
Southgate KM, Fisher M, Banning AP, Thurston VJ, Baker AH, Fabunmi RP, Groves PH, Davies M, Newby AC: Upregulation of basement membrane-degrading metalloproteinase secretion after balloon injury of pig carotid arteries. Circ Res 79: 1177–1187, 1996
Tyagi SC, Meyer L, Schmaltz RA, Reddy HK, Voelker DJ: Proteinases and restenosis in the human coronary artery: Extracellular matrix production exceeds the expression of proteolytic activity. Atherosclerosis 116: 43–57, 1995
Lee RT, Schoen FJ, Loree HM, Lark MW, Libby P: Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis. Implications for plaque rupture. Arterioscler Thromb Vasc Biol 16: 1070–1073, 1996
Newby AC, Zaltsman AB: Fibrous cap formation or destruction — the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Cardiovasc Res 41: 345–360, 1999
Zaltsman AB, Newby AC: Increased secretion of gelatinases A and B from the aortas of cholesterol fed rabbits: Relationship to lesion severity. Atherosclerosis 130: 61–70, 1997
Todor DR, Lewis I, Bruno G, Chyatte D: Identification of a serum gelatinase associated with the occurrence of cerebral aneurysms as promatrix metalloproteinase-2. Stroke 29: 1580–1583, 1998
Russell JC, Graham SE, Richardson M: Cardiovascular disease in the JCR:LA-cp rat. Mol Cell Biochem 188: 113–126, 1998
Saward L, Zahradka P: Coronary artery smooth muscle in culture: Migration of heterogeneous cell populations from vessel wall. Mol Cell Biochem 176: 53–59, 1997
Tyagi SC, Matsubara L, Weber KT: Direct extraction and estimation of collagenase(s) activity by zymography in microquantities of rat myocardium and uterus. Clin Biochem 26: 191–198, 1993
Fabunmi RP, Baker AH, Murray EJ, Booth RF, Newby AC: Divergent regulation by growth factors and cytokines of 95 and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1,-2, and-3 in rabbit aortic smooth muscle cells. Biochem J 315: 335–342, 1996
Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Libby P: Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann NY Acad Sci 748: 501–507, 1995
Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, Lark MW, Amento E, Libby P: Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 75: 181–189, 1994
Richardson M, Schmidt AM, Graham SE, Achen B, DeReske M, Russell JC: Vasculopathy and insulin resistance in the JCR:LA-cp rat. Atherosclerosis 138: 135–146, 1998
Bond M, Fabunmi RP, Baker AH, Newby AC: Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett 435: 29–34, 1998
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wilson, D., Massaeli, H., Russell, J.C., Pierce, G.N., Zahradka, P. (2003). Low matrix metalloproteinase levels precede vascular lesion formation in the JCR:LA-cp rat. In: Gilchrist, J.S.C., Tappia, P.S., Netticadan, T. (eds) Biochemistry of Diabetes and Atherosclerosis. Developments in Molecular and Cellular Biochemistry, vol 42. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-9236-9_19
Download citation
DOI: https://doi.org/10.1007/978-1-4419-9236-9_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4852-8
Online ISBN: 978-1-4419-9236-9
eBook Packages: Springer Book Archive